TriSalus Life Sciences Inc
NASDAQ:TLSI
Intrinsic Value
The intrinsic value of one TLSI stock under the Base Case scenario is 6.76 USD. Compared to the current market price of 4.57 USD, TriSalus Life Sciences Inc is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
TriSalus Life Sciences Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
TriSalus Life Sciences Inc
Balance Sheet Decomposition
TriSalus Life Sciences Inc
Current Assets | 25.1m |
Cash & Short-Term Investments | 13m |
Receivables | 5.5m |
Other Current Assets | 6.6m |
Non-Current Assets | 3.5m |
PP&E | 3.1m |
Other Non-Current Assets | 424k |
Free Cash Flow Analysis
TriSalus Life Sciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
TriSalus Life Sciences Inc
Revenue
|
38.6m
USD
|
Cost of Revenue
|
-5.6m
USD
|
Gross Profit
|
33m
USD
|
Operating Expenses
|
-76.5m
USD
|
Operating Income
|
-43.5m
USD
|
Other Expenses
|
-826k
USD
|
Net Income
|
-44.3m
USD
|
TLSI Profitability Score
Profitability Due Diligence
TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
TLSI Solvency Score
Solvency Due Diligence
TriSalus Life Sciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
TriSalus Life Sciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TLSI Price Targets Summary
TriSalus Life Sciences Inc
According to Wall Street analysts, the average 1-year price target for TLSI is 11.54 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for TLSI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TLSI stock under the Base Case scenario is 6.76 USD.
Compared to the current market price of 4.57 USD, TriSalus Life Sciences Inc is Undervalued by 32%.